Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Primary Lymphoid Organs01:16

Primary Lymphoid Organs

14.3K
Primary lymphoid organs are pivotal in the formation, development, and maturation of lymphocytes, the white blood cells that serve as the backbone of our immune system. This crucial function underscores their fundamental role in maintaining our overall health and immunity. The two primary lymphoid organs of prime importance are the red bone marrow and the thymus.
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
14.3K
Skin Cancer01:30

Skin Cancer

5.6K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
5.6K
Secondary Lymphoid Organs01:15

Secondary Lymphoid Organs

8.6K
Secondary organs, including lymph nodes, the spleen, and mucosa-associated lymphoid tissue (MALT), work harmoniously to protect us from disease and infection.
The spleen is a vital organ in the lymphatic system, nestled in the upper left side of the abdomen. It is composed of two primary regions: the red pulp and the white pulp, each having distinct functions. The red pulp performs a significant role in blood filtration. It efficiently purges the blood of old or damaged red blood cells and...
8.6K
B Cell Activation and Differentiation01:24

B Cell Activation and Differentiation

15.6K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
15.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

RETRACTED: Zito Marino et al. AXL and MET Tyrosine Kinase Receptors Co-Expression as a Potential Therapeutic Target in Malignant Pleural Mesothelioma. <i>J. Pers. Med.</i> 2022, <i>12</i>, 1993.

Journal of personalized medicine·2026
Same author

Plantar basal cell carcinoma: a rare location.

Italian journal of dermatology and venereology·2026
Same author

Post-mortem microbiology (PMM) as diagnostic tool in sudden unexpected childhood deaths.

Legal medicine (Tokyo, Japan)·2026
Same author

Bridging Trials and Real Life in Fixed-Duration BTKi-Venetoclax for CLL: A Delphi-Enhanced Synthesis Incorporating Artificial Intelligence (AI) Benchmarks.

European journal of haematology·2026
Same author

Evolution of hematopoietic stem cell potential from preterm to term neonates.

HemaSphere·2026
Same author

Correction: Mosca et al. Sarcoma Common MHC-I Haplotype Restricts Tumor-Specific CD8+ T Cell Response. <i>Cancers</i> 2022, <i>14</i>, 3414.

Cancers·2026
Same journal

Explainable incremental-value analysis of apparent diffusion coefficient and arterial spin labeling radiomics for ATRX status prediction in glioblastoma.

Frontiers in oncology·2026
Same journal

Study-level factors associated with hematoma after ultrasound-guided vacuum-assisted breast lesion excision: a systematic review and meta-analysis using a T-P-B framework.

Frontiers in oncology·2026
Same journal

Feasibility and strategy analysis of radiotherapy consolidation following immunotherapy for stage IV esophageal squamous cell carcinoma.

Frontiers in oncology·2026
Same journal

Anastomosing hemangioma of the kidney: a case report.

Frontiers in oncology·2026
Same journal

Machine learning-based prediction of prolonged air leak after uniportal video-assisted thoracic surgery segmentectomy.

Frontiers in oncology·2026
Same journal

Past present and future of radiosensitization in cervical cancer.

Frontiers in oncology·2026
See all related articles

Related Experiment Video

Updated: Dec 18, 2025

Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from S&#233;zary Syndrome Patients for Transcriptomic Profiling
09:08

Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling

Published on: October 14, 2021

6.1K

Primary Cutaneous B-Cell Lymphomas: An Update.

Paola Vitiello1, Antonello Sica2, Andrea Ronchi3

  • 1Dermatology Unit, University of Campania Luigi Vanvitelli, Naples, Italy.

Frontiers in Oncology
|June 13, 2020
PubMed
Summary
This summary is machine-generated.

Primary cutaneous B-cell lymphomas (PCBCLs) are skin-exclusive lymphomas with distinct subtypes. Indolent types like PCMZL and PCFCL have excellent prognoses, while aggressive PCDLBCL, LT has a poorer outlook.

Keywords:
EBV-positive mucocutaneous ulcerdiffuse large B-cell lymphomaintravascular large B-cell lymphomaleg typeprimary cutaneous follicle-center cell lymphomaprimary cutaneous marginal zone lymphoma

More Related Videos

Bioprinting of Hydrogel Tumor Slices as a 3D Model for Mantle Cell Lymphoma
08:31

Bioprinting of Hydrogel Tumor Slices as a 3D Model for Mantle Cell Lymphoma

Published on: September 12, 2025

675
VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma
15:07

VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma

Published on: December 28, 2015

27.1K

Related Experiment Videos

Last Updated: Dec 18, 2025

Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from S&#233;zary Syndrome Patients for Transcriptomic Profiling
09:08

Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling

Published on: October 14, 2021

6.1K
Bioprinting of Hydrogel Tumor Slices as a 3D Model for Mantle Cell Lymphoma
08:31

Bioprinting of Hydrogel Tumor Slices as a 3D Model for Mantle Cell Lymphoma

Published on: September 12, 2025

675
VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma
15:07

VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma

Published on: December 28, 2015

27.1K

Area of Science:

  • Oncology
  • Dermatology
  • Hematology

Background:

  • Primary cutaneous B-cell lymphomas (PCBCLs) are a distinct group of non-Hodgkin lymphomas involving the skin.
  • PCBCLs constitute approximately 25% of all cutaneous lymphomas.
  • The World Health Organization (WHO) 2017 classification identifies three major subgroups: primary cutaneous marginal zone lymphoma (PCMZL), primary cutaneous follicle-center cell lymphoma (PCFCL), and diffuse large B-cell lymphoma, leg type (PCDLBCL, LT).

Purpose of the Study:

  • To provide an overview of the classification, diagnosis, and management of primary cutaneous B-cell lymphomas.
  • To highlight the prognostic differences between indolent and aggressive PCBCL subtypes.
  • To emphasize the multidisciplinary approach required for optimal patient care.

Main Methods:

  • Histological examination with immunohistochemical staining is crucial for diagnosis.
  • Classification follows the World Health Organization (WHO) 2017 guidelines.
  • Treatment strategies are tailored based on histological classification, disease presentation, and risk assessment.

Main Results:

  • PCMZL and PCFCL are indolent lymphomas with a high 5-year disease-specific survival rate (≥95%).
  • PCDLBCL, LT is an aggressive lymphoma with a 5-year survival rate below 60%.
  • Treatment varies from observation to local or systemic therapy, depending on disease extent and patient factors.

Conclusions:

  • PCBCLs exhibit significant heterogeneity in clinical presentation and prognosis.
  • Accurate histological and immunohistochemical diagnosis is essential for appropriate management.
  • Multidisciplinary collaboration among dermatologists, pathologists, and hemato-oncologists ensures optimal patient outcomes.